Publications by authors named "Alexandre Perrier"

Claim this Profile
D
Deciphering dual clinical entities associated with TP53 pathogenic variants: Insights from 53,085 HBOC panel analyses in French laboratories.
Edwige Kasper, Flavie Boulouard, Noémie Basset, Lisa Golmard, Hela Sassi, Alexandre Perrier

Int J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Immunodeficiency Virus Impairs Immune Responses to Tumor Neoepitopes Without Altering Mutational Profiles in NSCLC.
Baptiste Abbar, Karim Labreche, Jacques Cadranel, Marianne Veyri, Véronique Morin, Alexandre Perrier

J Thorac Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Somatic Genetic Variants in Superficial Vascular Malformations by Liquid Biopsy in a Cohort of 88 Patients from a French Hospital.
Franck Neil El Sissy, Annouk Bisdorff, Alexandre Perrier, Erell Guillerm, Jérôme Denis

Mol Diagn Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged response to osimertinib in three patients with refractory metastatic pancreatic adenocarcinomas with exon 19 deletion: a case report and literature review.
Timothée Vigié, Alexandre Perrier, Brice Chanez, Julien De Martino, Loëtitia Favre

Ther Adv Med Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PrP controls epithelial-to-mesenchymal transition in EGFR-mutated NSCLC: implications for TKI resistance and patient follow-up.
Claire Lailler, Audrey Didelot, Simon Garinet, Hugo Berthou, Marine Sroussi, Alexandre Perrier

Oncogene· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebral dural arteriovenous fistulas in patients with PTEN-related hamartoma tumor syndrome.
Anna Gerasimenko, Cyril Mignot, Olivier Naggara, Florence Coulet, Samar Ekram, Alexandre Perrier

Clin Genet· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lynch syndrome: influence of additional susceptibility variants on cancer risk.
Roseline Vibert, Jasmine Hasnaoui, Alexandre Perrier, Alexandra Lefebvre, Chrystelle Colas

Eur J Hum Genet· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOLFIRI in advanced platinum-resistant/refractory small-cell lung cancer: a retrospective study.
Cyril Roussel-Simonin, Paul Gougis, Donia Lassoued, Aurore Vozy, Marianne Veyri, Alexandre Perrier

Acta Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic strategies to overcome EGFR mutations as acquired resistance mechanism in ALK-rearranged non-small-cell lung cancer: Case Reports.
Lionel Michaux, Alexandre Perrier, Camille Mehlman, Hussa Alshehhi, Antonin Dubois

Front Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma.
Patrick R Benusiglio, Fikret Elder, Mehdi Touat, Alexandre Perrier, Marc Sanson

JCO Precis Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-invasive prenatal diagnosis of single gene disorders with enhanced relative haplotype dosage analysis for diagnostic implementation.
Mathilde Pacault, Camille Verebi, Magali Champion, Lucie Orhant, Alexandre Perrier

PLoS One· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Léo Mas, Alexandre Perrier, Florence Coulet, Jean-Baptiste Bachet

Bull Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of a pathogenic Alu element insertion in PALB2 gene from targeted NGS diagnostic data.
Mélanie Eyries, Olivier Ariste, Gaelle Legrand, Noémie Basset, Erell Guillerm, Alexandre Perrier

Eur J Hum Genet· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunohistochemistry as a tool to identify ELP1-associated medulloblastoma.
Arnault Tauziède-Espariat, Léa Guerrini-Rousseau, Alexandre Perrier, Jacob Torrejon, Flavia Bernardi

Acta Neuropathol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Clinical use and evolution of circulating biomarkers in the era of personalized oncology: From protein markers to bioclinical scores].
Alexandre Perrier, Pierre Hainaut, Pierre-Jean Lamy, Alexandre Guenoun, Dinh-Phong Nguyen

Bull Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Moving towards a personalized oncology: The contribution of genomic techniques and artificial intelligence in the use of circulating tumor biomarkers].
Alexandre Perrier, Pierre Hainaut, Alexandre Guenoun, Dinh-Phong Nguyen, Pierre-Jean Lamy

Bull Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical evolution of meningiomatosis after discontinuation of cyproterone acetate: clinical cases and histomolecular characterization.
Thibault Passeri, Lorenzo Giammattei, Tuan Le Van, Rosaria Abbritti, Alexandre Perrier

Acta Neurochir (Wien)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Atypical evolution of meningiomatosis after discontinuation of cyproterone acetate: clinical cases and histomolecular characterization.
Thibault Passeri, Lorenzo Giammattei, Tuan Le Van, Rosaria Abbritti, Alexandre Perrier

Acta Neurochir (Wien)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical assessment of the miR-34, miR-200, ZEB1 and SNAIL EMT regulation hub underlines the differential prognostic value of EMT miRs to drive mesenchymal transition and prognosis in resected NSCLC.
Simon Garinet, Audrey Didelot, Thomas Denize, Alexandre Perrier, Guillaume Beinse

Br J Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors.
Alexandre Perrier, Audrey Didelot, Pierre Laurent-Puig, Hélène Blons, Simon Garinet

Biomolecules· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies.
Alexandre Perrier, Pierre-Yves Boelle, Yves Chrétien, Joseph Gligorov, Jean-Pierre Lotz

PLoS One· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Development of molecular analysis by digital PCR for clinical practice: positioning, current applications and perspectives].
Jérôme Alexandre Denis, Alexandre Perrier, Juliette Nectoux, Pierre-Jean Lamy, Anne-Sophie Alary

Ann Biol Clin (Paris)· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The extracellular domain of Her2 in serum as a biomarker of breast cancer.
Alexandre Perrier, Joseph Gligorov, Guillaume Lefèvre, Mathieu Boissan

Lab Invest· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis